TTRX
Income statement / Annual
Last year (2024), Turn Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Turn Therapeutics Inc.'s net income was -$1.77 M.
See Turn Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
| Period Ended |
12/31/2024 |
12/31/2023 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$245.96 K
|
$7.50 K
|
| General & Administrative Expenses |
$1.55 M
|
$2.30 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.55 M
|
$2.30 M
|
| Other Expenses |
$0.00
|
$0.00
|
| Operating Expenses |
$1.80 M
|
$2.31 M
|
| Cost And Expenses |
$1.80 M
|
$2.31 M
|
| Interest Income |
$28.71 K
|
$15.88 K
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
$47.48 K
|
$43.92 K
|
| EBITDA |
-$1.75 M |
-$2.26 M |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$28.71 K
|
$15.88 K
|
| Income Before Tax |
-$1.77 M
|
-$2.29 M
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
| Net Income |
-$1.77 M
|
-$2.29 M
|
| Net Income Ratio |
0
|
0
|
| EPS |
0 |
0 |
| EPS Diluted |
0 |
0 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
| Link |
|
|
